Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00308906 · ClinicalTrials.gov registry record

Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children

A clinical trial of Infection and Renal Dysfunction, sponsored by Virginia Commonwealth University.

Completed
Registry status
166
Enrollment target
2
Study locations

NCT00308906 is a study of Infection and Renal Dysfunction that has completed, run by Virginia Commonwealth University. The registered enrollment target is 166 participants, below the 722-participant average among 41 other Infection trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00308906, a study of Infection and Renal Dysfunction, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
166 participants
Enrollment target
2
Study locations

Study Summary

The purposes of this study are to identify potential gene and protein markers of aminoglycoside-induced kidney injury in infants, children and adolescents treated with aminoglycoside antibiotics.

Conditions Studied

Infection Renal Dysfunction

Interventions

  • DRUG aminoglycoside

Study Locations (2)

Kentucky

  • University of Lousiville - Louisville

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 166 participants
Start Date 2006-06
Est. Completion 2010-12

Sponsor

Virginia Commonwealth University

558 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00308906

The ClinicalTrials.gov registry entry for NCT00308906 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 722-participant average among 41 other Infection trials with a reported enrollment target (77% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Infection appearing as the primary indexed condition, and to 1 intervention - of which aminoglycoside is the first listed.

NCT00308906 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, Virginia.

Frequently Asked Questions

What is clinical trial NCT00308906 about?

NCT00308906 is a clinical study titled "Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children". The purposes of this study are to identify potential gene and protein markers of aminoglycoside-induced kidney injury in infants, children and adolescents treated with aminoglycoside antibiotics.

What is the current status of trial NCT00308906?

This trial is currently completed. The enrollment target is 166 participants. The study started on 2006-06. Estimated completion is 2010-12.

What conditions does trial NCT00308906 study?

This clinical trial studies the following conditions: Infection, Renal Dysfunction.

What interventions are being tested in trial NCT00308906?

The interventions under investigation include: aminoglycoside (DRUG).

Who is sponsoring clinical trial NCT00308906?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00308906 being conducted?

This trial has 2 study locations across Kentucky, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Infection

All registered trials for this condition

Renal Dysfunction

All registered trials for this condition

Kentucky

All trials with a study site in Kentucky

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.